Skip to main content
. 2017 Jul 18;23(5):239–247. doi: 10.5761/atcs.oa.17-00045

Table 2. Summary of perioperative CGM data.

CGM value Preoperative Intraoperative Postoperative p value


During CIII During SQII (CIII vs. SQII)

Mean (mg/dL) 107.1 ± 19.3 143.9 ± 36.1 127.5 ± 8.2 141.3 ± 25.0 <0.01*
SD (mg/dL) 21.2 ± 8.4 29.1 ± 20.8 19.5 ± 8.1 28.8 ± 16.3 <0.01*
Max (mg/dL) 168.4 ± 38.6 191.4 ± 64.0 179.1 ± 30.5 219.8 ± 63.5 <0.01*
Min (mg/dL) 67.9 ± 16.0 96.7 ± 21.1 90.7 ± 12.5 89.2 ± 17.4 0.46
≤70 mg/dL     0.1 ± 0.6 (%) 0.6 ± 2.6 (%) <0.01*
71–179 mg/dL     97.1 ± 5.5 (%) 86.4 ± 19.0 (%) <0.01*
≥180 mg/dL     2.8 ± 5.2 (%) 13.0 ± 18.2 (%) <0.01*

*Value is statistically significant. p value: Paired t-test; CGM: continuous glucose monitoring; CIII: continuous intravenous insulin infusion; SQII: subcutaneous insulin infusion; SD: standard deviation